Patents by Inventor Nicholas Izzo

Nicholas Izzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260166006
    Abstract: The present disclosure relates to methods of treating neurological diseases, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein. The present disclosure relates to the methods of treating Parkinson's disease and Dementia with Lewy Bodies, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.
    Type: Application
    Filed: February 4, 2026
    Publication date: June 18, 2026
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Anthony CAGGIANO, Susan M. CATALANO, Mary HAMBY, Nicholas IZZO, Gary C. LOOK, Gilbert M. RISHTON
  • Publication number: 20240165077
    Abstract: The present disclosure relates to methods of treating neurological diseases, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein. The present disclosure relates to the methods of treating Parkinson's disease and Dementia with Lew Bodies, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.
    Type: Application
    Filed: March 17, 2022
    Publication date: May 23, 2024
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Anthony CAGGIANO, Susan M. CATALANO, Mary HAMBY, Nicholas IZZO, Gary C. LOOK, Gilbert M. RISHTON
  • Publication number: 20240009168
    Abstract: The present disclosure relates to methods of treating dry age-related macular degeneration (dry AMD), comprising administering to a subject in need thereof, a therapeutically effective amount of a compound or pharmaceutical composition according to any embodiment described herein.
    Type: Application
    Filed: December 10, 2021
    Publication date: January 11, 2024
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Anthony CAGGIANO, Susan CATALANO, Mary HAMBY, Nicholas IZZO, Gary LOOK, Gilbert RISHTON
  • Publication number: 20230098944
    Abstract: The present disclosure relates to methods of decreasing amyloid ? monomers and methods of treating cognitive decline in a subject, wherein the treatment results in an increase in amyloid ? oligomers and a reduction in cognitive decline. The present disclosure relates to treating cognitive decline, wherein target engagement can be measured in the clinic after treating.
    Type: Application
    Filed: February 12, 2021
    Publication date: March 30, 2023
    Applicant: Cognition Therapeutics, Inc.
    Inventors: Susan CATALANO, Nicholas IZZO
  • Publication number: 20050090532
    Abstract: Compounds having a structure according to Formula (I): are effective in a method of increasing erythropoietin and vascularization of tissue in a subject in need thereof.
    Type: Application
    Filed: November 9, 2004
    Publication date: April 28, 2005
    Inventors: Ji-In Almstead, Nicholas Izzo, David Jones, Richard Kawamoto